Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Venous Thrombosis”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Large-scale testing (Phase 3)Study completedNCT00740493
What this trial is testing

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Who this might be right for
Recurrent Venous ThromboembolismIdiopathic Deep Vein Thrombosis
University Hospital, Brest 104
Not applicableStudy completedNCT05413317
What this trial is testing

Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence

Who this might be right for
Pulmonary Embolism
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 115
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Not applicableEnded earlyNCT00428441
What this trial is testing

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Università degli Studi dell'Insubria 73
Not applicableStudy completedNCT05360641
What this trial is testing

Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.

Who this might be right for
Portal Vein ThrombosisLocal Cause
University Hospital, Caen 154
Large-scale testing (Phase 3)Study completedNCT01285661
What this trial is testing

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

Who this might be right for
Deep Vein Thrombosis of Lower LimbLower Extremity Deep Venous Thrombosis Recurrent
University of Padova 584
Testing effectiveness (Phase 2)UnknownNCT02486484
What this trial is testing

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Who this might be right for
NeovascularizationMacular DegenerationDiabetic Retinopathy+5 more
Rafic Hariri University Hospital 100
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Not applicableStudy completedNCT02546817
What this trial is testing

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 29
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Post-approval studies (Phase 4)Study completedNCT01989845
What this trial is testing

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Who this might be right for
RivaroxabanCancer-associated ThrombosisRecurrence+1 more
Seoul National University Hospital 127
Large-scale testing (Phase 3)Looking for participantsNCT04257487
What this trial is testing

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Who this might be right for
Venous ThromboembolismAnticoagulantElderly
Arianna Anticoagulazione Foundation 1,455
Not applicableStudy completedNCT00157599
What this trial is testing

MDA D-Dimer / Recurrent DVT Study

Who this might be right for
Deep Vein Thrombosis
McMaster University 500
Large-scale testing (Phase 3)Study completedNCT02555111
What this trial is testing

Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Who this might be right for
Deep Vein ThrombosisChronic Portal Vein Thrombosis
Assistance Publique - Hôpitaux de Paris 112
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableLooking for participantsNCT06372730
What this trial is testing

Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT)

Who this might be right for
Pulmonary EmbolismVenous Thromboembolism
University Hospital, Brest 665
Post-approval studies (Phase 4)Study completedNCT00264277
What this trial is testing

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 600
Load More Results